<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25885">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02769780</url>
  </required_header>
  <id_info>
    <org_study_id>Nexus Narcolepsy Registry</org_study_id>
    <nct_id>NCT02769780</nct_id>
  </id_info>
  <brief_title>A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy</brief_title>
  <official_title>A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jazz Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PatientCrossroads</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Up Narcolepsy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Narcolepsy Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jazz Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nexus is a collaboration between academic institutions, advocacy and industry to answer
      important questions about narcolepsy. It is a web-based observational study of
      patient-reported outcomes in adult patients with narcolepsy, with follow-up every six
      months.

      Nexus website: www.narcolepsyregistry.com
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Descriptive epidemiology of type 1 and type 2 narcolepsy</measure>
    <time_frame>Participants complete a survey every 6 months for 3 years after enrollment</time_frame>
    <description>Assessments include disease/diagnosis characteristics, disease/symptom characteristics, health-related quality of life (HRQoL), functioning, work productivity, resource utilization, and comorbidity burden at the time of enrollment and their progression through the course of the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication utilization and treatment outcomes for type 1 and type 2 narcolepsy</measure>
    <time_frame>Participants complete a survey every 6 months for 3 years after enrollment</time_frame>
    <description>Assessments include: Medication use, non-pharmacologic disease management, symptom relief, quality of life (QoL), functionality and productivity associated with varying treatment regimens at baseline and their change throughout the course of the study</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Narcolepsy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients with narcolepsy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Diagnosed with narcolepsy by a doctor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathleen F Villa, MS</last_name>
    <role>Study Director</role>
    <affiliation>Jazz Pharmaceuticals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jed Black, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jazz Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathleen F Villa, MS</last_name>
    <phone>650-496-2764</phone>
    <email>Kathleen.Villa@jazzpharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jazz Pharmaceuticals</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.narcolepsyregistry.com</url>
    <description>Narcolepsy Registry</description>
  </link>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 11, 2016</lastchanged_date>
  <firstreceived_date>March 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Narcolepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
